Ondansetron Injection, Solution
Product Images NDC 0409-2271

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 0409-2271). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Ondansetron 01)

Chemical structure of Ondansetron, showing its fused ring system including an indole and a substituted imidazole group, along with associated hydrochloride and hydrate components.*

FDA Label Image

Logo (Ondansetron 02)

FDA Label Image

Principal Display Panel (2 mL Vial Label)

Ondansetron Injection, USP 4 mg/2 mL (2 mg/mL) single-dose vial label showing a 2 mL vial. The label includes storage instruction to protect from light and indicates Rx only. Distributed by Hospira, Inc., Lake Forest, IL. Includes a barcode and NDC 0409-2271-02.*

FDA Label Image

Principal Display Panel (2 mL Vial Carton.)

Ondansetron Injection USP 4 mg/2 mL (2 mg/mL) solution box label for 25 single-dose fliptop vials. The label includes storage information, ingredients, and the distributor Hospira, Inc. The product is for intramuscular or intravenous injection and labeled with NDC 0409-2271-25.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.